• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病5XFAD小鼠模型中大脑脂联素受体表达的改变

Altered Brain Adiponectin Receptor Expression in the 5XFAD Mouse Model of Alzheimer's Disease.

作者信息

Pratap Anishchal A, Holsinger R M Damian

机构信息

Laboratory of Molecular Neuroscience and Dementia, Brain and Mind Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia.

Discipline of Pathology, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.

出版信息

Pharmaceuticals (Basel). 2020 Jul 12;13(7):150. doi: 10.3390/ph13070150.

DOI:10.3390/ph13070150
PMID:32664663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7407895/
Abstract

Metabolic syndromes share common pathologies with Alzheimer's disease (AD). Adiponectin, an adipocyte-derived protein, regulates energy metabolism via its receptors, AdipoR1 and AdipoR2. To investigate the distribution of adiponectin receptors (AdipoRs) in Alzheimer's, we examined their expression in the aged 5XFAD mouse model of AD. In age-matched wild-type mice, we observed neuronal expression of both ARs throughout the brain as well as endothelial expression of AdipoR1. The pattern of receptor expression in the aged 5XFAD brain was significantly perturbed. Here, we observed decreased neuronal expression of both ARs and decreased endothelial expression of AdipoR1, but robust expression of AdipoR2 in activated astrocytes. We also observed AdipoR2-expressing astrocytes in the dorsomedial hypothalamic and thalamic mediodorsal nuclei, suggesting the possibility that astrocytes utilise AdipoR2 signalling to fuel their activated state in the AD brain. These findings provide further evidence of a metabolic disturbance and demonstrate a potential shift in energy utilisation in the AD brain, supporting imaging studies performed in AD patients.

摘要

代谢综合征与阿尔茨海默病(AD)有着共同的病理特征。脂联素是一种由脂肪细胞分泌的蛋白质,通过其受体AdipoR1和AdipoR2调节能量代谢。为了研究脂联素受体(AdipoRs)在阿尔茨海默病中的分布,我们检测了它们在AD的5XFAD老年小鼠模型中的表达。在年龄匹配的野生型小鼠中,我们观察到两种受体在全脑的神经元中均有表达,且AdipoR1在内皮细胞中表达。5XFAD老年小鼠脑内受体的表达模式受到显著干扰。在此,我们观察到两种受体的神经元表达均减少,AdipoR1的内皮细胞表达也减少,但在活化的星形胶质细胞中AdipoR2表达强烈。我们还在背内侧下丘脑和丘脑背内侧核中观察到表达AdipoR2的星形胶质细胞,这表明星形胶质细胞可能利用AdipoR2信号来维持其在AD脑内的活化状态。这些发现为代谢紊乱提供了进一步的证据,并证明了AD脑内能量利用的潜在转变,支持了在AD患者中进行的影像学研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/7407895/4c4fbf7f8f8b/pharmaceuticals-13-00150-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/7407895/b9a4be9a1d5c/pharmaceuticals-13-00150-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/7407895/0316bee85eb3/pharmaceuticals-13-00150-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/7407895/9745bca5f653/pharmaceuticals-13-00150-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/7407895/f40c4af00eb4/pharmaceuticals-13-00150-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/7407895/4c4fbf7f8f8b/pharmaceuticals-13-00150-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/7407895/b9a4be9a1d5c/pharmaceuticals-13-00150-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/7407895/0316bee85eb3/pharmaceuticals-13-00150-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/7407895/9745bca5f653/pharmaceuticals-13-00150-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/7407895/f40c4af00eb4/pharmaceuticals-13-00150-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/7407895/4c4fbf7f8f8b/pharmaceuticals-13-00150-g005.jpg

相似文献

1
Altered Brain Adiponectin Receptor Expression in the 5XFAD Mouse Model of Alzheimer's Disease.阿尔茨海默病5XFAD小鼠模型中大脑脂联素受体表达的改变
Pharmaceuticals (Basel). 2020 Jul 12;13(7):150. doi: 10.3390/ph13070150.
2
Altered Brain Leptin and Leptin Receptor Expression in the 5XFAD Mouse Model of Alzheimer's Disease.阿尔茨海默病5XFAD小鼠模型中脑内瘦素及瘦素受体表达的改变
Pharmaceuticals (Basel). 2020 Nov 18;13(11):401. doi: 10.3390/ph13110401.
3
Adiponectin suppresses amyloid-β oligomer (AβO)-induced inflammatory response of microglia via AdipoR1-AMPK-NF-κB signaling pathway.脂联素通过 AdipoR1-AMPK-NF-κB 信号通路抑制小胶质细胞中淀粉样β寡聚体 (AβO) 诱导的炎症反应。
J Neuroinflammation. 2019 May 25;16(1):110. doi: 10.1186/s12974-019-1492-6.
4
Adiponectin Receptors Are Less Sensitive to Stress in a Transgenic Mouse Model of Alzheimer's Disease.在阿尔茨海默病转基因小鼠模型中,脂联素受体对应激的敏感性较低。
Front Neurosci. 2017 Apr 11;11:199. doi: 10.3389/fnins.2017.00199. eCollection 2017.
5
Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer's disease.脂联素模拟新型九肽可挽救阿尔茨海默病中异常的神经元代谢相关记忆缺陷。
Mol Neurodegener. 2021 Apr 13;16(1):23. doi: 10.1186/s13024-021-00445-4.
6
Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity.脂联素通过脂联素受体 1 控制β淀粉样毒性下脑内皮细胞的细胞凋亡和紧密连接蛋白的表达。
Cell Death Dis. 2017 Oct 12;8(10):e3102. doi: 10.1038/cddis.2017.491.
7
Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons.脂联素受体在下丘脑中表达,并与啮齿动物弓状核神经元中的阿黑皮素原和神经肽Y共定位。
J Endocrinol. 2009 Jan;200(1):93-105. doi: 10.1677/JOE-08-0348. Epub 2008 Oct 29.
8
A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse.负能量平衡与阿尔茨海默病的人源化临床前模型5XFAD小鼠下丘脑的代谢功能障碍有关。
Int J Mol Sci. 2021 May 20;22(10):5365. doi: 10.3390/ijms22105365.
9
Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.脂联素受体 1(AdipoR1)和 AdipoR2 在体内介导血管再生和代谢功能障碍中的作用不同。
J Biol Chem. 2014 Jun 6;289(23):16200-13. doi: 10.1074/jbc.M114.548115. Epub 2014 Apr 17.
10
Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.海马突触和星形胶质细胞代谢紊乱是阿尔茨海默病 5xFAD 小鼠模型早期淀粉样蛋白病理的主要事件。
Cell Death Dis. 2021 Oct 16;12(11):954. doi: 10.1038/s41419-021-04237-y.

引用本文的文献

1
Neuroprotection through adiponectin receptor agonist: an updated meta-analysis of preclinical Alzheimer's disease studies.通过脂联素受体激动剂实现神经保护:阿尔茨海默病临床前研究的最新荟萃分析。
BMC Neurol. 2025 Aug 4;25(1):320. doi: 10.1186/s12883-025-04356-5.
2
Chronic β3 adrenergic agonist treatment improves neurovascular coupling responses, attenuates blood-brain barrier leakage and neuroinflammation, and enhances cognition in aged mice.慢性β3肾上腺素能激动剂治疗可改善老年小鼠的神经血管耦合反应,减轻血脑屏障渗漏和神经炎症,并增强认知能力。
Aging (Albany NY). 2025 Feb 19;17(2):448-463. doi: 10.18632/aging.206203.
3
Adiponectin as a potential mediator of the pro-cognitive effects of physical exercise on Alzheimer's disease.

本文引用的文献

1
Chronic oral administration of adipoRon reverses cognitive impairments and ameliorates neuropathology in an Alzheimer's disease mouse model.阿杜罗恩经口慢性给药可逆转阿尔茨海默病小鼠模型的认知障碍并改善神经病理学。
Mol Psychiatry. 2021 Oct;26(10):5669-5689. doi: 10.1038/s41380-020-0701-0. Epub 2020 Mar 4.
2
Adiponectin as Link Factor between Adipose Tissue and Cancer.脂联素作为脂肪组织与癌症之间的关联因子。
Int J Mol Sci. 2019 Feb 15;20(4):839. doi: 10.3390/ijms20040839.
3
Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis.
脂联素作为体育锻炼对阿尔茨海默病认知促进作用的潜在介质。
Neural Regen Res. 2025 Jan 29;21(1):96-106. doi: 10.4103/NRR.NRR-D-23-00943.
4
Advancing Alzheimer's Disease Modelling by Developing a Refined Biomimetic Brain Microenvironment for Facilitating High-Throughput Screening of Pharmacological Treatment Strategies.通过开发优化的仿生脑微环境来推进阿尔茨海默病建模,以促进药理学治疗策略的高通量筛选。
Int J Mol Sci. 2024 Dec 30;26(1):241. doi: 10.3390/ijms26010241.
5
Distinct roles of ADIPOR1 and ADIPOR2: A pan-cancer analysis.ADIPOR1 和 ADIPOR2 的不同作用:泛癌症分析。
Front Endocrinol (Lausanne). 2023 Feb 21;14:1119534. doi: 10.3389/fendo.2023.1119534. eCollection 2023.
6
Non-Pharmacological Therapeutic Options for the Treatment of Alzheimer's Disease.治疗阿尔茨海默病的非药物治疗选择。
Int J Mol Sci. 2022 Sep 20;23(19):11037. doi: 10.3390/ijms231911037.
7
Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy.神经退行性疾病中的神经酰胺和鞘氨醇-1-磷酸及其在治疗中的潜在作用。
Int J Mol Sci. 2022 Jul 15;23(14):7806. doi: 10.3390/ijms23147806.
8
Altered Brain Leptin and Leptin Receptor Expression in the 5XFAD Mouse Model of Alzheimer's Disease.阿尔茨海默病5XFAD小鼠模型中脑内瘦素及瘦素受体表达的改变
Pharmaceuticals (Basel). 2020 Nov 18;13(11):401. doi: 10.3390/ph13110401.
阿尔茨海默病发病早期的神经元-细胞相互作用之外。
Nat Rev Neurosci. 2019 Feb;20(2):94-108. doi: 10.1038/s41583-018-0113-1.
4
Insulin Resistance in Alzheimer's Disease.阿尔茨海默病中的胰岛素抵抗
Front Neurosci. 2018 Nov 13;12:830. doi: 10.3389/fnins.2018.00830. eCollection 2018.
5
Exercise-induced brain-derived neurotrophic factor expression: Therapeutic implications for Alzheimer's dementia.运动诱导的脑源性神经营养因子表达:对阿尔茨海默病痴呆的治疗意义。
Ageing Res Rev. 2018 Dec;48:109-121. doi: 10.1016/j.arr.2018.10.002. Epub 2018 Oct 13.
6
Recombinant CTRP9 administration attenuates neuroinflammation via activating adiponectin receptor 1 after intracerebral hemorrhage in mice.重组 CTRP9 给药通过激活脑出血后小鼠的脂联素受体 1 减轻神经炎症。
J Neuroinflammation. 2018 Jul 30;15(1):215. doi: 10.1186/s12974-018-1256-8.
7
Metabolic brain networks in aging and preclinical Alzheimer's disease.衰老和临床前阿尔茨海默病中的代谢大脑网络。
Neuroimage Clin. 2017 Dec 28;17:987-999. doi: 10.1016/j.nicl.2017.12.037. eCollection 2018.
8
Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism.神经退行性疾病中的下丘脑改变及其与异常能量代谢的关系。
Front Mol Neurosci. 2018 Jan 19;11:2. doi: 10.3389/fnmol.2018.00002. eCollection 2018.
9
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.2 型糖尿病和阿尔茨海默病中的脑胰岛素抵抗:概念与难题。
Nat Rev Neurol. 2018 Mar;14(3):168-181. doi: 10.1038/nrneurol.2017.185. Epub 2018 Jan 29.
10
Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease.健康老年人的体重减轻可能是临床前阿尔茨海默病的一种非认知性体征。
Oncotarget. 2017 Oct 31;8(62):104706-104716. doi: 10.18632/oncotarget.22218. eCollection 2017 Dec 1.